Dr. Maccecchini
from Meeting Podcast Hosted by Parkinson's Body and Mind
Topic: about a new medication (Buntanetap) which is in Phase 3. Dr. Maccecchini founded Annovis in May 2008 to develop better therapeutics for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Meeting Podcast?
This episode is 24 minutes long.
When was this Meeting Podcast episode published?
This episode was published on June 28, 2023.
Can I download this Meeting Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.